Olema Pharmaceuticals Inc (OLMA)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-01-13 | 2025-01-08 | B Purchase |
Bain Capital Life Sciences Investors, LLC Large shareholder |
300,000
+4.0%
5.76USD 1,727,370 |
300,000 +4.0% | 5.76 | USD 1,727,370 | |
| 2024-12-17 | 2024-12-17 | S Sale | Non-Executive Director |
700,761
-100.0%
6.75USD 4,730,137 |
700,761 -100.0% | 6.75 | USD 4,730,137 | |
| 2024-12-11 | 2024-12-11 | S Sale | Non-Executive Director |
179
-0.0%
9.39USD 1,681 |
179 -0.0% | 9.39 | USD 1,681 | |
| 2024-12-11 | 2024-12-11 | S Sale | Non-Executive Director |
7,958
-1.0%
8.66USD 68,916 |
7,958 -1.0% | 8.66 | USD 68,916 | |
| 2024-12-11 | 2024-12-11 | S Sale |
CH. OPERATING & FINANCIAL OFF. Officer |
406
-0.1%
9.39USD 3,812 |
406 -0.1% | 9.39 | USD 3,812 | |
| 2024-12-11 | 2024-12-11 | S Sale |
CH. OPERATING & FINANCIAL OFF. Officer |
17,950
-3.2%
8.66USD 155,447 |
17,950 -3.2% | 8.66 | USD 155,447 | |
| 2024-12-11 | 2024-12-11 | S Sale |
CH. DISCOV. & NON-CLIN DEV OFF Officer |
300
-0.1%
9.39USD 2,817 |
300 -0.1% | 9.39 | USD 2,817 | |
| 2024-12-11 | 2024-12-11 | S Sale |
CH. DISCOV. & NON-CLIN DEV OFF Officer |
13,314
-2.2%
8.66USD 115,299 |
13,314 -2.2% | 8.66 | USD 115,299 | |
| 2024-12-11 | 2024-12-11 | S Sale |
PRESIDENT AND CEO Executive Director |
1,267
-0.5%
9.39USD 11,897 |
1,267 -0.5% | 9.39 | USD 11,897 | |
| 2024-12-11 | 2024-12-11 | S Sale |
PRESIDENT AND CEO Executive Director |
55,907
-18.7%
8.66USD 484,155 |
55,907 -18.7% | 8.66 | USD 484,155 | |
| 2024-12-11 | 2024-12-11 | S Sale |
CHIEF MEDICAL OFFICER Officer |
320
-0.3%
9.39USD 3,005 |
320 -0.3% | 9.39 | USD 3,005 | |
| 2024-12-11 | 2024-12-11 | S Sale |
CHIEF MEDICAL OFFICER Officer |
14,202
-10.9%
8.66USD 122,989 |
14,202 -10.9% | 8.66 | USD 122,989 | |
| 2024-12-11 | 2024-12-10 | S Sale | Non-Executive Director |
8,256
-1.1%
9.37USD 77,359 |
8,256 -1.1% | 9.37 | USD 77,359 | |
| 2024-12-11 | 2024-12-10 | S Sale |
CH. OPERATING & FINANCIAL OFF. Officer |
16,803
-2.9%
9.37USD 157,444 |
16,803 -2.9% | 9.37 | USD 157,444 | |
| 2024-12-11 | 2024-12-10 | S Sale |
CH. DISCOV. & NON-CLIN DEV OFF Officer |
12,452
-2.0%
9.38USD 116,800 |
12,452 -2.0% | 9.38 | USD 116,800 | |
| 2024-12-11 | 2024-12-10 | S Sale |
PRESIDENT AND CEO Executive Director |
52,328
-14.9%
9.37USD 490,313 |
52,328 -14.9% | 9.37 | USD 490,313 | |
| 2024-12-11 | 2024-12-10 | S Sale |
CHIEF MEDICAL OFFICER Officer |
13,283
-9.3%
9.37USD 124,462 |
13,283 -9.3% | 9.37 | USD 124,462 | |
| 2024-08-05 | 2024-08-01 | S Sale |
Paradigm Biocapital Advisors LP Large shareholder |
529,501
-40.3%
14.92USD 7,897,507 |
529,501 -40.3% | 14.92 | USD 7,897,507 | |
| 2024-08-05 | 2024-08-01 | S Sale |
Paradigm Biocapital Advisors LP Large shareholder |
1,870,499
-28.4%
14.92USD 27,898,493 |
1,870,499 -28.4% | 14.92 | USD 27,898,493 | |
| 2024-07-31 | 2024-07-30 | PS Planned sale | Non-Executive Director |
934
-0.1%
15.55USD 14,524 |
934 -0.1% | 15.55 | USD 14,524 |